HS 3003 · 30

Find verified buyers for
Pharmaceutical compounds (bulk)

HS 3003 covers medicaments consisting of two or more constituents mixed for therapeutic use, not put up in measured doses. Bulk pharma compounds from Indian APIs, widely exported to regulated and semi-regulated markets. India exported $3.2 billion of Pharmaceutical compounds (bulk) (HS 3003) globally in FY24-25 (DGFT data). The key export markets are USA, UK, UAE, GERMANY, JAPAN. Select a destination market below to see the full tariff, NTM, and buyer-discovery breakdown.

India exports $3.2 billion/yr for HS 3003·5 key destination markets·100% BANT-verified buyers

Top Indian manufacturing clusters for HS 3003

Ahmedabad
Gujarat
India's denim capital; major pharma API and bulk-chemicals exporter
Vadodara
Gujarat
Major pharma API and specialty-chemicals exporter
Mumbai
Maharashtra
India's financial + pharma capital; major textile and gem-jewellery export hub

Indicative cluster mapping. Data current as of FY24-25 unless otherwise noted.

Common certifications for HS 3003 exports

USFDAEU-GMPWHO-GMPCEP / COS

Certification requirements vary by destination market and sub-heading. Verify current requirements with DGFT, relevant EPCs, and the destination country's import authority before shipment.

Want a full market analysis for HS 3003?

diipl's free Custom Product Report covers tariff corridors, top importers, CAGR, price benchmarks, and a recommended entry strategy — produced within 24 business hours.